Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)

NCT: NCT06483945 · ACTIVE_NOT_RECRUITING

NCT IDNCT06483945
StatusACTIVE_NOT_RECRUITING
Start Date2024-02-28
Completion2028-06-30
SponsorDexCom, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

"To evaluate the use of the Dexcom CGM System when used according to approved commercial labeling during standard clinical use and its impact on intended users in a real-world setting"

Frequently Asked Questions

What is Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)?

Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry) is a clinical trial registered under NCT06483945. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06483945?

The current status of NCT06483945 (Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)) is: ACTIVE_NOT_RECRUITING.

When did Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry) start?

Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry) started on 2024-02-28.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.